[1]
Bulut, I. and Yegin Katran, Z. 2026. Reclassification of NSAID hypersensitivity according to the WAO 2025 guidelines: insights from a cohort of 527 patients. Allergologia et Immunopathologia. 54, 1 (Jan. 2026), 166–171. DOI:https://doi.org/10.15586/aei.v54i1.1579.